Search research articles
Contact Us
Filters
Showing results (61-70 of 102) with videos related to
Page
of 11
Sort By:
Scandinavian Journal of Rheumatology
|
July 9, 2009
Rituximab therapy in patients with rheumatoid arthritis refractory or with contraindication to anti-tumour necrosis factor drugs: real-life experience in Finnish patients
H Valleala, M Korpela, T Möttönen, et al.
Rheumatology (Oxford, England)
|
August 30, 2007
The expression of SOCS is altered in rheumatoid arthritis
P Isomäki, T Alanärä, P Isohanni, et al.
Arthritis and Rheumatism
|
April 1, 1997
Perinuclear antineutrophil cytoplasmic antibody in rheumatoid arthritis: a marker of severe disease with associated nephropathy
A Mustila, M Korpela, J Mustonen, et al.
Applied and Environmental Microbiology
|
July 6, 2006
Intrinsic properties of so-called dormant probiotic bacteria, determined by flow cytometric viability assays
Sampo J Lahtinen, Arthur C Ouwehand, Johanna P Reinikainen, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 6, 2001
Serum matrix metalloproteinase-2 as a prognostic marker in advanced cutaneous melanoma
M S Vuoristo, P Kellokumpu-Lehtinen, L M Parvinen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
August 26, 1998
Effect of acetaldehyde and acetylsalicylic acid on HbA1c chromatography in the FPLC method with Mono S cation exchanger
L K Koskinen, M M Korpela, J T Lahtela, et al.
Melanoma Research
|
July 13, 2000
The value of serum S-100beta and interleukins as tumour markers in advanced melanoma
M S Vuoristo, P Kellokumpu-Lehtinen, S Laine, et al.
Nephron. Clinical Practice
|
April 25, 2008
Measurement of the kidney function in patients with rheumatoid arthritis: plasma cystatin C versus 51Cr-EDTA clearance
Krista Karstila, Aimo P T Harmoinen, Terho J Lehtimäki, et al.
Oral Diseases
|
November 10, 2004
Oral findings in coeliac disease and Sjögren's syndrome
P Patinen, L Aine, P Collin, et al.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1995
Intermittent interferon and polychemotherapy in metastatic melanoma
M S Vuoristo, P Gröhn, P Kellokumpu-Lehtinen, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 102) with videos related to
Sort By:
Page
of 11
Scandinavian Journal of Rheumatology
|
July 9, 2009
Rituximab therapy in patients with rheumatoid arthritis refractory or with contraindication to anti-tumour necrosis factor drugs: real-life experience in Finnish patients
H Valleala, M Korpela, T Möttönen, et al.
Rheumatology (Oxford, England)
|
August 30, 2007
The expression of SOCS is altered in rheumatoid arthritis
P Isomäki, T Alanärä, P Isohanni, et al.
Arthritis and Rheumatism
|
April 1, 1997
Perinuclear antineutrophil cytoplasmic antibody in rheumatoid arthritis: a marker of severe disease with associated nephropathy
A Mustila, M Korpela, J Mustonen, et al.
Applied and Environmental Microbiology
|
July 6, 2006
Intrinsic properties of so-called dormant probiotic bacteria, determined by flow cytometric viability assays
Sampo J Lahtinen, Arthur C Ouwehand, Johanna P Reinikainen, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 6, 2001
Serum matrix metalloproteinase-2 as a prognostic marker in advanced cutaneous melanoma
M S Vuoristo, P Kellokumpu-Lehtinen, L M Parvinen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
August 26, 1998
Effect of acetaldehyde and acetylsalicylic acid on HbA1c chromatography in the FPLC method with Mono S cation exchanger
L K Koskinen, M M Korpela, J T Lahtela, et al.
Melanoma Research
|
July 13, 2000
The value of serum S-100beta and interleukins as tumour markers in advanced melanoma
M S Vuoristo, P Kellokumpu-Lehtinen, S Laine, et al.
Nephron. Clinical Practice
|
April 25, 2008
Measurement of the kidney function in patients with rheumatoid arthritis: plasma cystatin C versus 51Cr-EDTA clearance
Krista Karstila, Aimo P T Harmoinen, Terho J Lehtimäki, et al.
Oral Diseases
|
November 10, 2004
Oral findings in coeliac disease and Sjögren's syndrome
P Patinen, L Aine, P Collin, et al.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1995
Intermittent interferon and polychemotherapy in metastatic melanoma
M S Vuoristo, P Gröhn, P Kellokumpu-Lehtinen, et al.
Page
of 11